Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Alicante – page 17

316 clinical trials in Alicante, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Alicante at a glance
316
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

316 trials in Alicante

Open in trial search

Study on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:ABCSG GmbH

Study of Amivantamab and Cetrelimab for Patients with Metastatic Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen Cilag International

Study of Atezolizumab, Trastuzumab, and Vinorelbine for Patients with Advanced HER2-Positive Breast Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Atezolizumab
  • Sponsor:Solti Group

Neurodermatitis

Not recruiting

Study on the Effects of Barzolvolimab for Patients with Prurigo Nodularis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Iodide
  • Sponsor:Faraday Pharmaceuticals Inc.

Conjunctivitis allergic+3

Not recruiting

Study on the Effectiveness and Safety of Clustoid MM09 for Patients with Allergic Rhinitis or Rhinoconjunctivitis, with or without Mild to Moderate Asthma

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dermatophagoides Farinae Allergoid, Glutaraldehyde-Modified
  • Sponsor:Inmunotek S.L.

Breast cancer+7

Not recruiting

Study of sacituzumab govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:GBG Forschungs GmbH

Study of remibrutinib for long-term treatment of adult patients with chronic spontaneous urticaria who completed previous remibrutinib studies

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Alopecia areata

Not recruiting

Study of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BI 1839100
  • Sponsor:Boehringer Ingelheim Espana S.A.

Urticaria chronic+2

Not recruiting

Study on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Remibrutinib
  • Sponsor:Novartis Pharma AG

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Alicante

What the registry says about research in the country

01 Oncology Research

Current studies focus on advanced treatments for non-small cell lung cancer, including both early-stage and metastatic cases. Investigations are ongoing in acute myeloid leukemia and lymphoma treatments.

  • Lung Cancer Therapies
  • Blood Cancer Treatments
  • Immunotherapy Approaches

Research emphasizes innovative combination therapies and targeted treatments for better patient outcomes.

02 Dermatological Studies

Comprehensive research into treatments for plaque psoriasis and atopic dermatitis, with multiple trials evaluating new therapeutic approaches for moderate to severe cases.

  • Psoriasis Management
  • Dermatitis Treatments
  • Prurigo Nodularis Research

Studies focus on developing effective solutions for chronic skin conditions.

03 Cardiovascular Research

Investigations into hypertrophic cardiomyopathy and post-heart attack treatments, including studies on specialized stent therapies and antiplatelet medications.

  • Heart Disease Management
  • Cardiomyopathy Treatment
  • Post-Infarction Care

Focus on improving outcomes for patients with various cardiac conditions.

04 Immunology and Allergies

Clinical trials examining treatments for allergic rhinoconjunctivitis and responses to various allergens, including specialized immunotherapy approaches.

  • Allergy Treatments
  • Immunotherapy Development
  • Respiratory Conditions

Research aims to improve allergy management and treatment effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.